Clear Street Markets LLC Amgen Inc Call Options Transaction History

Clear Street Markets LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Oct 20, 2021	BUY	$212.27 - $248.7 $1,273 - $1,492	6 Added 25.0%	30 $638,000
Q1 2021 Apr 14, 2021	SELL	$221.91 - $258.6 $1,331 - $1,551	-6 Reduced 20.0%	24 $597,000
Q3 2020 Oct 19, 2020	SELL	$234.65 - $260.95 $15,017 - $16,700	-64 Reduced 68.09%	30 $762,000
Q2 2019 Jul 16, 2019	BUY	$166.7 - $195.41 $12,169 - $14,264	73 Added 347.62%	94 $1.73 Million
Q1 2019 May 09, 2019	BUY	$180.87 - $203.88 $180 - $203	1 Added 5.0%	21 $399,000
Q4 2018 Jan 23, 2019	SELL	$178.4 - $208.25 $356 - $416	-2 Reduced 9.09%	20 $389,000
Q2 2018 Jul 27, 2018	BUY	$166.05 - $186.51 $3,653 - $4,103	22 New	22 $406,000
Q4 2017 Feb 01, 2018	SELL	$168.79 - $188.59 $10,127 - $11,315	-60 Closed	0 $0
Q3 2017 Oct 30, 2017	BUY	$167.29 - $191.0 $10,037 - $11,460	60	60 $1.12 Million

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Clear Street Markets LLC, based on Form 13F filings with the SEC.

Stay updated on Clear Street Markets LLC with notifications on news.